US Stocks
/
Neumora Therapeutics, Inc. Share Price

Neumora Therapeutics, Inc. Share Price

NASDAQ: NMRA | Micro Cap
$0.48
+$0.01 (1.12%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neumora Therapeutics, Inc. Stock Performance

Open
$0.46
Prev. Close
$0.47
Circuit Range
N/A
Day Range
$0.45 - $0.49
Year Range
$0.45 - $3.65
Volume
61,426
Average Traded
$0.47

Neumora Therapeutics, Inc. Share Price Today

As of 9 October 2026, Neumora Therapeutics, Inc.'s share price is $0.48. The stock opened at $0.46, compared to its previous close of $0.47. During today's trading session, Neumora Therapeutics, Inc.'s share price traded between $0.45 and $0.49, with an average price of $0.47. Over the past 52 weeks, the stock has recorded a high of $3.65 and a low of $0.45. In terms of performance, Neumora Therapeutics, Inc.'s share price has declined by 80.54% over the last six months and is down 84.05% on a year-on-year basis.

Neumora Therapeutics, Inc. Share Price Chart

$0.45$0.49
L
Show Current Price
H

Neumora Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$78.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-477.87%
Profit Margin
N/A
Debt to Equity
1.19
Quarterly Earnings Growth YoY
24.10%

Neumora Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$56.76-$59.45-$53.46-$43.08
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-4.74%10.08%19.42%

Neumora Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$235.93-$243.79-$236.93
Net Profit MarginN/AN/AN/A
Income ChangeN/A-3.33%2.81%

About Neumora Therapeutics, Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Neumora Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.61
$0.48
-20.23%
Sep 2026
$1.33
$0.61
-58.92%
Aug 2026
$1.62
$1.48
-8.07%
Jul 2026
$1.69
$1.61
-4.73%
Jun 2026
$1.85
$1.69
-8.65%
May 2026
$2.46
$1.85
-24.80%
Apr 2026
$1.99
$2.46
+26.48%
Mar 2026
$2.85
$1.95
-44.11%
Feb 2026
$2.05
$3.48
+74.87%
Jan 2026
$1.79
$1.99
+11.48%
Dec 2025
$2.50
$1.78
-20.31%
Nov 2025
$3.04
$2.24
-25.33%

NMRA Share Price FAQs

What is Neumora Therapeutics, Inc. share price today?

chevron-up
Neumora Therapeutics, Inc. share price today is $0.48 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Neumora Therapeutics, Inc. stock?

chevron-up
The 52 week high of Neumora Therapeutics, Inc. stock is $3.65, while the 52 week low is $0.45 as of 9 Oct '26.

What is NMRA's market capitalisation today?

chevron-up
NMRA market capitalisation is $78.20M as of October 9, 2026, at 4:45 pm IST.

What is NMRA's net income for the last quarter?

chevron-up
NMRA's net income for the last quarter is -43.08B USD.

What is the 5 year returns of NMRA?

chevron-up
The 5 year returns of NMRA is -96.61% as on 9 Oct '26.

What is the high & low stock price of NMRA today?

chevron-up
NMRA stock price hit a high of $0.49 and low of $0.45 as of 9 Oct '26.

Can I buy NMRA shares in India?

chevron-up
Yes. You can buy NMRA in India by opening an international trading account.